MENU
CLSD
Stock ticker:
PRICE
CHANGE
CAPITALIZATION
Clearside Biomedical (CLSD) Ownership - Who owns Clearside Biomedical?
Industry: @Pharmaceuticals Major
Profile
Industry
Pharmaceuticals Major
Address
900 North Point Parkway
Phone
+1 678 270-3631
Employees
30
Web
https://www.clearsidebio.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
86.7M
P/E Ratio
N/A
Total Cash
29.36M
Projected Growth
N/A
Total Debt
863K
Revenue
7.52M
Risk (Beta)
1.91
Dividend Yield
N/A
Total Cash/Share
0.39
Total Debt/Equity
N/A
Revenue/Share
0.11 USD as % of share price
Fundamentals
CLSD
Capitalization
86.7M
P/E Ratio
N/A
Risk (Beta)
1.91
Dividend Yield
N/A
Total Cash
29.4M
Total Cash/Share
0.39
Total Debt
863K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.11%
Revenue
7.52M
ROE
N/A
Book Value
-28.29M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
-0.5
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
74K
Current Ratio
5.07
Current Revenue Per Employee
3000.00
Dividends Per Share - Security
N/A
EBITDA
-23.71M
Float
N/A
Float - Current
N/A
Gross Income Margin
100.00
Revenue To Assets
-91.51
Shares Held By Institutions
24.4M
Shares Outstanding - Current
74.7M
Total Liabilities
62.2M
Total Volume MTD
N/A
Value
-1
Gain YTD
-4.274
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of drug therapies to treat chronic, blinding diseases of the eye
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
900 North Point Parkway
Phone
+1 678 270-3631
Employees
30
Web
https://www.clearsidebio.com